BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19365778)

  • 1. Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles.
    Cekić ND; Milić JR; Savić SD; Savić MM; Jović Z; Daniels R
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1092-102. PubMed ID: 19365778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterisation of phenytoin-loaded alginate and alginate-chitosan microparticles.
    Cekić ND; Savić SD; Milić J; Savić MM; Jović Z; Malesević M
    Drug Deliv; 2007 Nov; 14(8):483-90. PubMed ID: 18027177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
    Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
    Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats.
    Onishi H; Koyama K; Sakata O; Machida Y
    Drug Dev Ind Pharm; 2010 Aug; 36(8):879-84. PubMed ID: 20345284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
    Agnihotri SA; Aminabhavi TM
    J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
    Coppi G; Iannuccelli V
    Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa.
    Simonoska Crcarevska M; Glavas Dodov M; Goracinova K
    Eur J Pharm Biopharm; 2008 Mar; 68(3):565-78. PubMed ID: 17651952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the pharmaceutical excipients in the tamoxifen activity on MCF-7 and vero cell cultures.
    Rossi T; Iannuccelli V; Coppi G; Bruni E; Baggio G
    Anticancer Res; 2009 Nov; 29(11):4529-33. PubMed ID: 20032401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate microparticles prepared by spray-coagulation method: preparation, drug loading and release characterization.
    Tu J; Bolla S; Barr J; Miedema J; Li X; Jasti B
    Int J Pharm; 2005 Oct; 303(1-2):171-81. PubMed ID: 16129575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and characterization of chitosan-coated alginate microcapsules containing albumin.
    Zheng CH; Liang WQ; Li F; Zhang YP; Fang WJ
    Pharmazie; 2005 Jun; 60(6):434-8. PubMed ID: 15997832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
    Lin CC; Fu CH
    Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems.
    Yu CY; Zhang XC; Zhou FZ; Zhang XZ; Cheng SX; Zhuo RX
    Int J Pharm; 2008 Jun; 357(1-2):15-21. PubMed ID: 18313867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
    Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
    Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.